Chemed (CHE) Accumulated Depreciation & Amortization (2010 - 2025)

Chemed has reported Accumulated Depreciation & Amortization for 16 years, with the latest figure at $388.1 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 1.6% year-over-year to $388.1 million; the trailing twelve-month figure through Dec 2025 stood at $388.1 million (up 1.6% YoY), and the FY2025 full-year result was $388.1 million, up 1.6% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $388.1 million, up from $382.0 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $388.1 million in Q4 2025, with the low at $317.9 million in Q4 2021.
• Average Accumulated Depreciation & Amortization over 5 years is $355.8 million, with a median of $354.9 million recorded in 2023.
• Year-over-year, Accumulated Depreciation & Amortization rose 8.36% in 2021 and advanced 1.6% in 2025.
• Tracing CHE's Accumulated Depreciation & Amortization over 5 years: stood at $317.9 million in 2021, then climbed by 5.66% to $335.9 million in 2022, then gained by 5.64% to $354.9 million in 2023, then rose by 7.64% to $382.0 million in 2024, then grew by 1.6% to $388.1 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $388.1 million (Q4 2025), $382.0 million (Q4 2024), and $354.9 million (Q4 2023), per Business Quant data.

Peer Comparison